No definition available.
Benign neoplasm: Ill-defined sites within the digestive system
CD2_BENIGN_DIGESTIVE_NOS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
208 |
4. Check minimum number of eventsNone |
208 |
5. Include endpointsNone |
208 |
6. Filter based on genotype QC (FinnGen only) |
208 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum systematis digestorii loco male specificato
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Ill-defined sites within the digestive system
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Ill-defined sites within the digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1435 | 836 | 586 |
| Only index persons | 1139 | 692 | 447 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 61.79 | 60.50 | 63.56 |
| Only index persons | 60.47 | 58.95 | 62.82 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 208 | 137 | 71 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.03 |
| Median age at first event (years) | 61.18 | 59.51 | 64.39 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 186
- Matched controls
- 1860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
+∞
205.2
157
*
21199
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Unspecified site
+∞
19.1
18
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
17.6
16.8
26
17
A09AA02
ATC
multienzymes (lipase, protease etc.)
21.6
16.0
23
12
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.9
14.4
31
41
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
23.2
12.3
17
8
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.5
10.9
41
111
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
63.8
10.8
12
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.0
10.6
79
368
TPH07
NOMESCO Finland
Cathetrisation of artery
4.7
10.4
37
94
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.9
8.9
29
67
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
13.6
8.5
14
11
2119X
ICD-9 Finland
Benign neoplasm of other parts of digestive system, Other and unspecified site[NEOPLASMA BENIGNUM ALIUD ORG DIGEST AL DEF SEU NUD]
+∞
8.4
8
*
A02BC02
ATC
pantoprazole; systemic
2.7
8.4
139
978
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
8.0
82
440
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
83.3
7.5
8
*
JAH00
NOMESCO Finland
Laparotomy
7.8
7.4
16
22
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
23.5
6.7
9
*
130
Kela drug reimbursment
Malignant tumour
4.3
6.7
24
62
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
6.6
64
327
ZXE00
NOMESCO Finland
One hour or less
2.2
6.6
89
539
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
8.1
6.2
13
17
WX402
NOMESCO Finland
General anaesthesia
2.9
6.0
40
163
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
60
198
3.85
15.94
3.7
3.3
umol/l
6.6
7.2
0.10
54
176
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
19
22
9.40
15.25
4.4
2.0
nmol/l
4.9
4.3
0.10
19
22
(3000570) Elastase.pancreatic [Mass/mass] in Stool
29
60
5.45
13.78
1.3
1.4
ug/g
281.0
289.0
0.06
20
30
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
59
214
3.45
13.38
4.4
4.3
ug/l
13.9
8.3
0.42
47
185
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
36
92
4.52
13.37
2.6
3.1
u/ml
582.1
1667.8
0.29
28
76
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
45
148
3.60
11.76
2.9
2.3
g/l
0.2
0.2
0.15
45
138
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
46
164
3.32
10.54
3.1
2.5
u/l
34.5
28.5
0.70
46
137
(3024561) Albumin [Mass/volume] in Serum or Plasma
128
783
2.65
10.50
6.6
4.4
g/l
35.2
35.1
0.03
121
736
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
100
580
2.39
8.69
3.5
2.4
u/l
62.1
56.8
0.65
93
538
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
96
547
2.40
8.69
3.7
3.3
u/l
34.4
30.4
0.52
91
527
(40768797) Stomach Pathology biopsy report
55
253
2.60
7.79
1.5
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
70
365
2.38
7.55
2.2
2.7
mosm/kgh2o
511.5
550.7
0.78
62
315
(3000991) Gas panel - Venous blood
37
146
2.87
7.00
5.2
6.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
45
4.28
6.78
1.2
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
48
225
2.47
6.44
1.6
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
128
904
2.08
6.07
7.3
6.1
mmol/l
1.2
1.2
0.05
106
763
(36304419) Bacteria [Presence] in Urine
80
486
2.05
5.64
3.4
2.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
108
736
1.97
5.45
9.5
8.4
inr
1.2
1.2
0.28
36
217
(3022948) Iron [Moles/volume] in Serum or Plasma
52
272
2.22
5.37
2.6
2.1
umol/l
12.5
13.0
0.17
46
250
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
22
5.22
5.32
1.4
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
64
368
2.07
5.17
2.4
2.5
e6/l
7.6
5.1
0.43
53
330
(3023368) Bacteria identified in Blood by Culture
77
474
1.99
5.15
5.3
4.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
86
552
1.95
5.09
3.4
3.1
e6/l
13.0
50.3
2.03
62
416
(42870588) Differential panel, method unspecified - Blood
86
556
1.93
4.95
6.2
5.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
25
96
2.82
4.94
5.6
4.6
mmol/l
24.3
25.1
0.51
25
96
(3030467) Casts [#/volume] in Urine by Automated count
80
512
1.91
4.70
3.4
2.9
e6/l
0.2
0.7
1.93
56
377
(3013826) Glucose [Moles/volume] in Serum or Plasma
136
1035
1.91
4.62
5.3
4.8
mmol/l
7.1
6.7
1.05
130
964
(3018095) Leukocytes [#/volume] in Urine
94
639
1.86
4.55
3.9
3.6
e6/l
98.8
75.2
0.15
67
448
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
44
233
2.13
4.35
2.9
2.2
%
19.6
22.4
0.66
37
205
(3022096) Basophils/100 leukocytes in Blood
106
758
1.81
4.28
7.8
5.5
%
0.6
0.7
0.23
100
709
(3018418) pH of Serum or Plasma
84
564
1.82
4.14
7.2
3.8
ph
7.4
7.4
0.40
20
103
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
112
822
1.79
4.08
7.9
5.4
mmol/l
1.2
1.2
0.10
107
748
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
56
334
1.93
3.98
3.4
3.5
ng/l
181.2
106.7
0.24
45
272
(3042936) Bacteria identified in Isolate by Culture
45
249
2.03
3.95
2.9
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
96
2.57
3.88
4.3
7.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
43
237
2.03
3.81
5.1
5.9
mmol/l
103.6
103.7
0.08
43
230
(3044889) 12 lead EKG panel
154
1257
1.87
3.79
4.0
4.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
108
796
1.74
3.78
7.6
5.5
%
58.7
57.8
0.37
102
750
(3019069) Monocytes/100 leukocytes in Blood
107
789
1.73
3.72
7.9
5.8
%
8.7
8.5
0.16
101
745
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
166
1395
1.94
3.64
13.2
7.5
u/l
85.2
78.1
0.97
161
1301
(3006504) Eosinophils/100 leukocytes in Blood
106
784
1.72
3.61
7.9
5.5
%
3.0
2.7
0.61
100
735
(3002030) Lymphocytes/100 leukocytes in Blood
108
805
1.71
3.56
7.9
5.7
%
25.5
27.3
1.05
102
752
(4062490)
9
17
5.48
3.55
1.2
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
127
996
1.71
3.42
17.1
9.6
e9/l
4.0
4.1
0.05
106
886
(3012516) Albumin [Mass/volume] in Urine
73
495
1.73
3.35
2.8
3.1
mg/l
1837.3
183.6
0.69
44
317
(3021589) Normoblasts [#/volume] in Blood
105
787
1.67
3.32
16.1
9.5
e9/l
0.0
0.0
0.19
83
650
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
90
649
1.68
3.28
3.4
3.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
39
219
1.96
3.27
7.1
4.7
mmol/l
1.1
1.1
0.01
39
205
(3001122) Ferritin [Mass/volume] in Serum or Plasma
97
716
1.66
3.22
3.6
2.5
ug/l
127.9
116.8
0.25
90
658
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
97
721
1.65
3.11
2.9
2.1
nmol/l
80.7
78.7
0.26
86
636
(40761536) Microorganisms panel - Urine sediment
29
150
2.08
3.03
3.8
3.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
37
210
1.93
3.00
1.6
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
130
2.14
2.96
1.4
1.6
—
—
—
0
0
(4035726)
32
175
1.98
2.88
1.7
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
109
845
1.61
2.88
8.1
5.4
e9/l
0.0
0.0
0.18
89
743
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
34
192
1.92
2.80
4.6
3.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
111
869
1.59
2.78
10.1
5.6
e9/l
0.2
0.2
0.41
93
772
(3021447) Carbon dioxide [Partial pressure] in Venous blood
31
171
1.96
2.73
3.5
3.5
kpa
6.0
5.8
0.36
31
166
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
46
289
1.76
2.71
3.2
2.9
e6/l
4.9
2.9
0.19
17
152
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
35
202
1.88
2.70
1.7
1.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
108
844
1.58
2.70
8.1
5.4
e9/l
0.6
0.6
0.28
88
739
(3018677) aPTT in Platelet poor plasma by Coagulation assay
44
277
1.75
2.57
1.8
1.8
s
29.7
29.4
0.17
44
269
(3019198) Lymphocytes [#/volume] in Blood
109
861
1.56
2.55
8.2
5.4
e9/l
1.7
2.0
0.74
92
768
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
44
278
1.74
2.53
1.7
2.0
—
—
—
0
0
(3012544) pH of Venous blood
31
178
1.87
2.43
3.5
3.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
51
341
1.66
2.38
5.8
3.0
mmol/l
2.4
2.5
0.30
46
300
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
7
17
4.22
2.38
1.4
1.2
u/l
59.3
57.4
—
7
12
(3003396) Base excess in Arterial blood by calculation
35
211
1.79
2.36
4.0
6.2
mmol/l
0.9
1.5
0.39
25
170
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
104
826
1.52
2.30
5.3
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
76
564
1.55
2.30
2.7
3.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
92
712
1.52
2.30
2.3
1.9
pmol/l
96.9
96.5
0.03
45
344
(3021387) Prolactin [Units/volume] in Serum or Plasma
9
29
3.20
2.25
1.9
1.4
mu/l
233.1
319.5
—
9
29
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
33
199
1.78
2.22
1.7
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
210
0.40
2.22
11.4
8.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
70
514
1.55
2.21
2.9
3.0
mmol/l
7.2
7.1
0.04
56
434
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
58
413
1.56
2.08
2.9
2.0
mg/l
3.5
3.2
0.27
53
355
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
46
310
1.62
2.08
3.2
2.7
e6/l
0.5
1.2
1.47
16
171
(3024928) Oxygen saturation in Venous blood
9
32
2.89
2.02
2.4
3.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
31
189
1.75
2.02
2.0
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
70
524
1.51
1.99
4.0
3.9
mg/mmol
4.3
9.7
1.07
42
321
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
33
2.80
1.95
1.6
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
33
2.80
1.95
1.6
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
11
4.63
1.95
1.2
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
16
3.83
1.95
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
162
1442
1.56
1.89
32.7
17.7
%
13.9
13.7
1.00
157
1414
(3019230) Fractional oxyhemoglobin in Venous blood
7
22
3.26
1.89
2.6
2.4
%
65.1
50.6
—
7
22
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
129
1097
1.46
1.89
4.5
3.2
u/l
64.2
51.1
0.64
120
1022
(40768804) Tissue Pathology biopsy report
91
725
1.45
1.88
2.9
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
74
2.11
1.80
1.1
2.2
g/l
7.6
7.7
—
8
64
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
74
2.11
1.80
1.1
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
74
2.11
1.80
1.1
2.2
g/l
4.0
3.8
—
8
61
(3044640) Blood type and Crossmatch panel - Blood
71
543
1.47
1.80
3.3
2.4
—
—
—
0
0
(44790047)
6
18
3.40
1.76
1.3
1.7
—
—
—
0
0
(44790049)
6
18
3.40
1.76
1.3
1.7
—
—
—
0
0
(44806118)
6
18
3.40
1.76
1.3
1.7
—
—
—
0
0
(44790048)
6
18
3.40
1.76
1.3
1.7
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
5
13
3.91
1.72
1.0
1.1
u/l
329.0
299.0
—
5
13
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
42
2.45
1.70
1.8
1.4
—
—
—
0
0
(4306422)
6
19
3.22
1.67
1.2
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
24
144
1.75
1.66
2.6
2.8
kpa
4.0
4.1
0.14
24
139
(3019550) Sodium [Moles/volume] in Serum or Plasma
192
1799
1.87
1.64
25.4
16.9
mmol/l
139.3
139.8
1.68
187
1750
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
70
2.07
1.63
1.1
2.3
g/l
3.1
3.2
—
8
63
(3000492) Spirometry study
24
145
1.74
1.63
1.4
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
14
3.63
1.62
1.0
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
17
92
1.92
1.61
3.8
3.6
pmol/l
4.1
4.4
1.50
17
79
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
7
26
2.75
1.59
2.3
1.2
nmol/l
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
185
1721
1.68
1.54
25.2
14.6
mg/l
27.6
22.5
1.19
159
1357
(4024509)
5
15
3.39
1.53
1.2
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
15
3.39
1.53
1.0
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
15
3.39
1.53
1.8
1.9
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
15
3.39
1.53
1.0
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
192
1805
1.83
1.53
25.9
17.0
mmol/l
4.0
4.0
0.54
187
1756
(3004588) Protein electrophoresis panel - Serum or Plasma
20
117
1.78
1.51
1.1
2.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
60
458
1.44
1.51
3.1
2.7
umol/l
325.8
8404.5
2.75
54
390
(3037467) Urinalysis macro (dipstick) panel - Urine
136
1194
1.40
1.50
4.8
4.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
6
137
0.42
1.46
3.8
3.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
103
869
1.37
1.43
3.7
3.9
estimate
0.0
0.0
0.00
25
175
(3020564) Creatinine [Moles/volume] in Serum or Plasma
193
1824
1.81
1.40
27.0
17.6
umol/l
80.8
76.2
0.78
193
1824
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
41
2.25
1.39
1.7
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
23
2.65
1.37
2.5
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
90
1.84
1.37
1.1
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
43
2.14
1.32
1.3
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
24
2.54
1.31
1.2
2.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
25
2.44
1.25
1.2
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
52
400
1.40
1.24
3.1
2.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
101
1.74
1.24
1.5
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
18
109
1.71
1.23
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
19
2.67
1.22
1.4
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
31
217
1.50
1.20
1.4
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
55
430
1.38
1.19
1.7
1.5
nmol/l
21.0
20.9
0.00
49
354
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
13
72
1.86
1.18
2.8
4.8
%
1.5
1.6
0.22
13
65
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
20
2.54
1.16
1.4
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
57
452
1.36
1.13
11.0
7.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
104
1.69
1.13
1.4
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
51
2.01
1.13
1.3
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
31
2.30
1.11
1.7
2.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
21
2.41
1.09
1.4
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
102
884
1.30
1.09
5.0
5.2
estimate
0.0
0.0
0.00
22
173
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
48
1.91
1.02
1.2
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
23
2.20
0.98
1.4
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
23
2.20
0.98
1.2
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
102
893
1.28
0.98
3.9
3.9
estimate
0.0
0.0
0.00
24
169
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
36
1.98
0.98
1.6
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
31
0.00
0.97
0.0
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
7
37
1.92
0.95
1.1
1.1
e6/l
0.6
2.4
—
7
28
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
7
37
1.92
0.95
1.1
1.2
e6/l
2.4
169.7
—
7
29
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
37
1.92
0.95
1.3
1.2
nmol/l
0.6
0.9
—
7
32
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
42
1.94
0.89
1.4
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
20
137
1.51
0.88
3.6
4.4
%
0.2
0.2
—
5
45
(3021901) Oxygen saturation in Capillary blood
6
30
2.03
0.87
2.3
2.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
173
1632
1.36
0.87
25.0
13.9
ml/min/173m2
77.1
78.1
0.22
149
1335
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
45
1.81
0.85
1.4
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
31
1.96
0.85
1.5
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
12
73
1.68
0.83
2.8
4.8
%
1.0
0.9
0.62
12
67
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
114
1.53
0.82
1.5
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
32
1.90
0.82
1.3
1.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
6
32
1.90
0.82
6.0
2.9
umol/l
31.0
34.8
—
6
24
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
14
210
0.64
0.82
4.1
4.5
%
30.3
32.5
—
7
137
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
26
0.00
0.79
0.0
3.6
—
20.3
—
0
7
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
26
0.00
0.79
0.0
1.0
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
6
34
1.79
0.77
8.2
2.2
kpa
5.6
4.9
—
6
34
(3027315) Oxygen [Partial pressure] in Blood
6
34
1.79
0.77
8.2
2.2
kpa
9.3
8.0
—
6
34
(4010399)
8
132
0.59
0.76
1.1
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
27
203
1.38
0.75
4.1
2.7
%
1.8
1.7
0.06
21
186
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
38
1.87
0.74
1.6
1.1
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
7
39
1.82
0.73
3.4
6.6
mmol/l
105.4
105.6
—
7
34
(3039000) Anion gap in Blood
7
39
1.82
0.73
3.4
6.6
mmol/l
12.0
10.3
—
7
34
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
25
2.02
0.73
2.6
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
40
1.78
0.72
1.3
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
168
0.64
0.71
1.3
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
46
379
1.27
0.70
6.0
4.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
27
1.87
0.69
1.6
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
27
1.87
0.69
2.6
2.9
e9/l
2.1
5.3
—
5
27
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
27
1.87
0.69
1.6
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
20
146
1.41
0.66
1.9
2.8
e9/l
67.3
70.8
0.21
15
115
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
28
1.80
0.66
2.6
3.8
%
44.4
60.7
—
5
28
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
190
1835
1.41
0.66
16.5
10.8
u/l
26.0
24.5
0.81
184
1770
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
44
1.61
0.66
2.1
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
29
227
1.32
0.64
9.1
20.0
inr
1.1
1.2
—
5
30
(3044290) Cell count panel - Cerebral spinal fluid
5
30
1.68
0.62
1.4
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
20
0.00
0.60
0.0
2.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
11
72
1.56
0.60
1.1
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
64
1.59
0.59
1.6
2.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
57
491
1.22
0.59
3.8
3.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
20
150
1.37
0.58
3.7
4.2
%
0.2
0.9
—
5
52
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
98
1.46
0.58
2.1
2.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
47
398
1.23
0.57
1.3
1.2
u/ml
0.5
1.8
1.62
12
118
(3019832) Treponema pallidum Ab [Presence] in Serum
5
86
0.57
0.57
1.6
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
133
0.66
0.54
4.8
2.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
39
1.55
0.53
1.0
6.4
—
—
—
0
0
(3010421) pH of Blood
6
39
1.55
0.53
8.3
2.4
ph
7.4
7.4
—
6
34
(3028626) Oxygen [Partial pressure] in Capillary blood
6
39
1.55
0.53
3.0
2.1
kpa
7.6
7.6
—
6
34
(3009542) Hematocrit [Volume Fraction] of Blood
159
1515
1.21
0.52
27.5
15.6
%
37.9
39.6
1.25
115
1058
(3011397) Hemoglobin [Presence] in Urine by Test strip
47
403
1.21
0.51
3.2
3.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
46
395
1.21
0.50
2.1
1.6
mg/l
1.3
1.4
0.08
41
309
(3015235) Bicarbonate [Moles/volume] in Capillary blood
7
47
1.51
0.48
4.0
2.1
mmol/l
25.7
25.6
—
7
37
(3029937) Albumin [Presence] in Urine by Test strip
55
485
1.18
0.45
4.3
4.0
estimate
0.0
0.0
0.00
23
167
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
167
1606
1.20
0.45
5.2
4.8
mu/l
1.9
1.9
0.12
157
1453
(1761868) Lipid panel - Serum or Plasma
66
592
1.17
0.44
2.7
3.1
—
—
—
0
0
(4094501)
7
51
1.39
0.44
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
51
1.39
0.44
2.3
2.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
21
167
1.29
0.44
1.4
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
8
56
1.45
0.43
1.3
2.6
g/l
0.0
0.0
—
8
56
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
8
56
1.45
0.43
1.3
2.6
g/l
0.0
0.0
—
8
56
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
8
57
1.42
0.42
1.3
2.6
g/l
0.0
0.0
—
8
57
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
31
260
1.23
0.42
1.5
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
170
1641
1.20
0.42
6.7
5.9
mmol/mol
41.1
40.2
0.55
160
1525
(3051651) Icteric interference index of Serum or Plasma
0
15
0.00
0.41
0.0
2.7
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
184
1790
1.24
0.41
21.2
13.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
17
0.00
0.41
0.0
1.3
—
64.4
—
0
11
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
75
684
1.15
0.40
4.0
4.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
61
1.32
0.40
1.6
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
13
98
1.35
0.38
1.0
1.1
iu/ml
392.5
148.2
—
6
41
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
36
1.40
0.38
1.4
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
71
1.28
0.36
1.8
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
34
293
1.19
0.36
1.2
1.3
u/ml
17.2
12.5
0.14
16
112
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
42
1.44
0.36
1.5
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
40
351
1.17
0.35
2.0
1.7
nmol/l
1200.5
1245.7
0.10
30
266
(3037522) Nuclear Ab [Titer] in Serum
26
219
1.21
0.35
1.3
1.4
titre
354.3
508.1
—
7
47
(3026361) Erythrocytes [#/volume] in Blood
193
1892
1.28
0.35
36.8
21.7
e12/l
4.4
4.4
0.31
188
1835
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
55
496
1.15
0.34
1.8
1.6
mmol/l
1.4
1.3
0.29
49
414
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
176
1712
1.18
0.34
4.7
4.8
mmol/l
6.0
6.0
0.08
163
1567
(1002224) Polysomnography panel
7
53
1.33
0.31
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
13
163
0.78
0.31
4.0
4.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
10
130
0.76
0.30
2.0
2.4
—
6.1
—
0
6
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
186
1.20
0.29
1.5
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
140
1348
1.12
0.28
4.2
4.0
pmol/l
14.6
14.8
0.54
128
1210
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
62
1.30
0.28
2.0
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
62
1.30
0.28
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
62
1.30
0.28
1.1
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
86
1.29
0.26
1.3
1.4
—
—
—
0
0
(4034850)
8
67
1.20
0.26
13.1
11.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
16
133
1.22
0.25
1.1
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
12
97
1.25
0.23
2.5
2.6
%
1.1
1.1
0.10
12
97
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
53
490
1.11
0.23
5.1
5.2
ug/l
2.0
2.8
0.43
47
432
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
42
1.20
0.21
1.0
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
10
0.00
0.21
0.0
2.4
—
7.2
—
0
10
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.0
—
0
5
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
108
1.22
0.20
1.5
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
14
0.00
0.20
0.0
1.4
—
30.2
—
0
9
(3052851) Hemolysis interference index of Serum or Plasma
7
59
1.19
0.18
4.3
3.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
61
1.15
0.17
1.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
61
1.15
0.17
1.3
2.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
8
70
1.15
0.16
4.3
3.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
42
391
1.09
0.16
4.6
4.5
%
24.8
20.9
0.58
14
191
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
101
977
1.07
0.15
3.0
2.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
32
296
1.10
0.14
2.7
3.1
ug/l
0.8
0.7
0.05
21
203
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
117
0.85
0.13
1.5
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
108
0.83
0.13
1.0
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
95
1.17
0.12
1.1
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
31
289
1.09
0.11
1.5
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
69
716
0.95
0.11
3.8
3.9
ng/l
42.0
38.8
0.06
46
517
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
168
1702
0.93
0.11
4.2
4.6
mmol/l
1.5
1.5
1.34
153
1557
(21494755) Public health laboratory ask at order entry panel
10
115
0.86
0.11
1.6
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
162
1640
0.94
0.09
3.7
4.1
mmol/l
1.2
1.3
0.91
150
1495
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
55
1.09
0.09
2.0
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
57
1.05
0.08
1.3
1.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
60
0.83
0.08
1.6
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
127
1.11
0.08
1.5
1.7
—
—
—
0
0
(3020891) Body temperature
6
72
0.83
0.08
9.2
4.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
13
119
1.10
0.06
2.5
4.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
170
1714
0.96
0.05
4.3
4.6
mmol/l
4.5
4.7
1.28
155
1576
(3000494) Fungus identified in Specimen by Culture
22
208
1.06
0.05
1.4
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
109
0.91
0.04
1.5
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
29
301
0.96
0.04
1.3
1.3
iu/ml
13.4
40.2
2.86
14
104
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
55
560
0.98
0.02
2.8
3.2
ng/l
1674.8
1172.5
0.28
47
476
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
176
1752
1.03
0.02
5.0
5.2
mmol/l
2.6
2.7
0.61
160
1605
(3013512) EKG study
54
548
0.98
0.01
3.3
4.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
11
104
1.06
0.01
3.5
3.1
kpa
5.4
5.2
0.39
11
95
(3028026) IgM [Mass/volume] in Serum or Plasma
11
104
1.06
0.01
1.2
1.9
g/l
1.4
1.4
0.04
11
96
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
40
396
1.01
0.00
2.1
1.7
pmol/l
398.8
449.2
0.78
30
324
(3000330) Specific gravity of Urine by Test strip
10
103
0.97
0.00
3.5
4.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
36
363
0.99
0.00
1.4
1.4
g/l
2.2
2.6
0.70
27
218
(3003694) ABO and Rh group [Type] in Blood
45
447
1.01
0.00
1.5
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
158
1.01
0.00
1.7
2.7
ml/min/173m2
72.4
62.1
—
7
66
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.0
—
130.8
—
0
8
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
62
0.97
0.00
1.8
1.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
98.3
—
0
6
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(3006576) Bicarbonate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
6.8
—
25.9
—
0
6
(3017704) Immunofixation for Urine
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
79
1.01
0.00
3.7
2.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
11.9
—
0
5
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
59
1.02
0.00
2.2
5.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
7
76
0.92
0.00
1.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_DIGESTIVE_NOS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_DIGESTIVE_NOS | 1.908 [1.49, 2.44] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.146 |
During the follow-up period (1.1.1998 — 31.12.2019), 158 out of 500 females with CD2_BENIGN_DIGESTIVE_NOS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_DIGESTIVE_NOS | 1.995 [1.48, 2.68] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 139 out of 332 males with CD2_BENIGN_DIGESTIVE_NOS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_DIGESTIVE_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.224% | 0.335% |
| 5 | 1.08% | 2.077% |
| 10 | 2.401% | 5.039% |
| 15 | 4.887% | 9.237% |
| 20 | 8.89% | 15.301% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_DIGESTIVE_NOS – Benign neoplasm: Ill-defined sites within the digestive system
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data